Abstract Colorectal cancer (CRC) remains a leading cause of cancer incidence and mortality worldwide, and metastatic disease responds poorly to conventional surgery, chemotherapy, and targeted therapy. Antibody-drug conjugates (ADCs) link monoclonal antibodies to cytotoxic payloads through chemical linkers, enabling antigen-specific delivery, intracellular payload release, bystander killing, and Fc-mediated immune effects.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile